ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (Nasdaq:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it will report its financial results for the second quarter and six months ended June 30, 2008 and certain future expectations after the stock market closes on Wednesday, August 6.
